Skip to main content
Premium Trial:

Request an Annual Quote

FDA's Classification of Genomics Breast Cancer Tests Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, May 11.
1. FDA Deems Genomic Breast Cancer Prognostics Class II Devices, Releases 'Special Controls' Guidance (from May 9)
2. Invitrogen's Onions Heads to BioReliance; Millipore to Replace CFO; Gene Logic Promotes Brinkerhoff; BIO Fleshes Out Board; and Others (from May 11)
3. 454, Malaysian Genomics Center Team on Sequencing Projects ( from May 7)
4. Luminex Posts Nearly 30 Percent Revenue Jump in Q1 (from May 7)
5. Epigenomics, Myriad to Hunt DNA Methylation Markers for Cancer Drug Response (from May 9)
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.